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http:WHAT THIS PAPER ADDS
The potential beneﬁt of endovascular aneurysm repair (EVAR) in the setting of aortic rupture is debated.
Retrospective studies have shown lower mortality after EVAR for rupture when compared with open repair but
these ﬁndings have not been replicated in randomized trials. In the current report, the outcome of ruptured AAA
repair was analyzed in a national registry based on the primary strategy for treatment at center level. The results
support the early ﬁndings of the randomized trials. The peri-operative and midterm mortality after ruptured AAA
is equal in a modern real world clinical setting, irrespective of the primary operative strategy.Objective/Background: In randomized trials, no peri-operative survival beneﬁt has been shown for endovascular
(EVAR) repair of ruptured abdominal aortic aneurysm (rAAA) when compared with open repair. The aim of this
study was to investigate the effect of primary repair strategy on early and midterm survival in a non-selected
population based study.
Methods: The Swedish Vascular Registry was consulted to identify all rAAA repairs performed in Sweden in the
period 2008e12. Centers with a primary EVAR strategy (treating > 50% of rAAA with EVAR) were compared with
centers with a primary open repair strategy. Peri-operative outcome, midterm survival, and incidence of rAAA
repair/100,000 inhabitants aged > 50 years were assessed.
Results: In total, 1,304 patients were identiﬁed. Three primary EVAR centers (pEVARc) operated on 236 patients
(74.6% EVAR). Twenty-six primary open repair centers (pORc) operated 1,068 patients (15.6% EVAR). Patients
treated at pEVARc were more often referrals (28.0% vs. 5.3%; p < .01), had a higher rate of respiratory
comorbidity (36.5% vs. 21.9%; p < .01), and higher pre-operative systolic blood pressure (84.3 vs. 72.3 mmHg;
p < .01). There was no difference in mortality based on primary treatment strategy at 30 days (pEVARc 28.0%,
n ¼ 66; pORc 27.4%, n ¼ 296 [p ¼ .87]), 1 year (pEVARc 39.9%, n ¼ 93; pORc 34.7%, n ¼ 366 [p ¼ .19]), or 2
years (42.1%, n ¼ 94; 38.3%, n ¼ 394 [p ¼ .28]), either overall or in subgroups based on age or referral status.
Overall, patients treated with EVAR were older (mean age 76.4 vs. 74.0 years; p < .01), and had a lower 30 day
mortality (EVAR 21.6%, n ¼ 74; odds ratio 29.6%, n ¼ 288 [p ¼ < .01]). Incidence of rAAA repair was lower in
pEVARc regions (6.07, 95% conﬁdence interval [CI] 5.01e7.13) when compared with pORc regions (8.15, 95% CI
7.64e8.66).
Conclusion: There was no difference in mortality after rAAA repair among centers with a primary EVAR approach
when compared with a primary open repair strategy, either peri-operatively or in the midterm. The study
supports the early ﬁndings of the randomized controlled trials in a national population based setting.
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Despite advances in medical care over the last few decades,
ruptured abdominal aortic aneurysm (rAAA) remains a
major threat to a patient’s life, with a 90% overall and 30e
50% in hospital mortality.1e4 The introduction of endovas-
cular aneurysm repair (EVAR) in the treatment of AAA has
resulted in reduced peri-operative mortality in the elective
setting,5,6 with widespread use of this technique over the
last decade for intact AAA repair.7,8 Although EVAR is
increasingly used for the treatment of rAAA, uptake has
Open or EVAR Strategy for Aortic Rupture 23been slower than in the elective setting, and the evidence
for EVAR in treatment of ruptures remains scarce.9e12 In an
international database on vascular surgical procedures in
nine countries, 12% of rAAAs were treated with EVAR.7
Theoretically, there are potential beneﬁts with EVAR of
rAAA. Patients can often be treated under local anesthesia.
General anesthesia in a bleeding patient is often associated
with deep hypotension, and laparotomy can be avoided. In
patients with obstructive lung disease, the risk of pulmo-
nary complications is reduced, and the minimally invasive
technique can potentially allow treatment of elderly co-
morbid patients who are otherwise not considered for open
surgical rAAA repair. However, a primary EVAR strategy for
rAAA could result in delayed control of aortic hemorrhage,
owing to the need for a computed tomography scan and
case planning prior to treatment. In addition, while vascular
centers traditionally have routines for urgent open aortic
cross clamping to stabilize patients in shock, endovascular
know how and operating facilities are often not available
24/7.
Although several reports indicate excellent short-term
outcome after EVAR for rAAA, the claimed superiority of
this treatment strategy compared with open repair is
debated.13,14 The superior outcome of EVAR for rAAA seen
in observational studies may be an effect of case selection,
making comparison with open repair inadequate.7,12 Three
randomized trials on open and endovascular treatment of
rAAA have been published.9,10,15 The results reported to
date do not indicate any difference in peri-operative mor-
tality, and long-term outcome data are not available.
Although the randomized controlled trials form an excellent
basis for comparison of these two operative techniques for
the treatment or rAAA, the randomized setting also includes
a selection bias, which may affect the generalizability.
Owing to the uncertainty regarding best treatment, the
primary strategy for treatment of rAAA varies signiﬁcantly
between centers. In Sweden, the rate of EVAR treatment of
ruptures varies from 0 to 100% between centers.
Registries with high validity contribute to evidence based
medicine through an opportunity to test the ﬁndings of
randomized trials in a real world setting.16 The current
report aims to assess the effect of primary treatment
strategy for rAAA on outcome in a contemporary
population-based national registry. The study focuses pri-
marily on treatment strategy, rather than treatment mo-
dality, with the hypothesis that centers with a primary EVAR
strategy would achieve different peri-operative mortality
after rAAA, and would treat older and more comorbid pa-
tients with rupture.METHODS
The Swedvasc registry, a nationwide prospective vascular
surgical registry in Sweden, validated internally and exter-
nally with > 90% coverage for AAA repair and 100% accu-
rate mortality data explained by automatic cross- linkage
with the population registry17 was investigated. All ruptured
AAA repairs performed in Sweden on Swedish citizens > 50years of age registered during the period May 2008e
December 2012 were identiﬁed. Operations performed at
centers with no elective aortic surgery were excluded from
the analysis. Patient characteristics, including age and pre-
operative comorbidities, were assessed.
To assess the effect of operative strategy for rAAA on
outcome, centers were divided into two groups. Hospitals
performing EVAR in > 50% of rAAA cases were classiﬁed as
primary EVAR strategy centers (pEVARc) versus those with a
< 50% rate of EVAR classiﬁed as primary open repair
strategy centers (pORc). Patient characteristics were
compared between groups, including the following comor-
bidities: cardiac disease (history of ischemic heart disease,
congestive heart failure or cardiac intervention/operation),
respiratory disease (any diagnosed pulmonary disease),
diabetes (diet, tablet, or insulin treated diabetes mellitus),
cerebrovascular disease (history of transient ischemic attack
or stroke) and renal disease (pre-operative creatinine level
[mmol/L]). Thirty day, 1 year, and 2 year survival, as well as
peri-operative complications, were analyzed. Data were
analyzed including and excluding referrals, an important
analysis as pEVARc were all referral centers. Referred pa-
tients were identiﬁed based on comparison of the local
residence address of the patient and operating center for
rAAA, based on zip code. A patient with a local vascular
centre in his/her residential area, but operated on at a
referral center covering the area, was deﬁned as a referral.
Patients that were operated on at a referral center not
covering their zip code area were not deﬁned as referrals, as
the patient is then more likely to have ruptured at a loca-
tion away from their residence. No patients were operated
on at a county hospital outside their residential zip code
area. Subgroup analyses were performed, assessing patient
characteristics and outcome, based on age and center level
(referral centers vs. county hospitals) and pre-operative
status. Uni- and multivariate analyses of predictors of
peri-operative mortality were performed.
There were no data available on the treatment turndown
rate for rAAA at different centers. To analyze variations in
the rate of treated rAAA, the incidence of rAAA surgery per
100,000 inhabitants > 50 years of age were assessed in
primary EVAR versus primary open repair centers for the
period 2009e12. Regional population data were retrieved
from Statistics Sweden.18 The rate of rAAA repair was
calculated based on number of registered rAAA repairs in
Swedvasc as proportion of population.Statistics
Independent samples t test was used for comparison of
normally distributed data. Missing values were handled by
case deletion. Rates were compared with the chi-square
test. For analysis of mortality, 30 day outcome was
assessed with the chi-square test, and midterm mortality
was estimated with KaplaneMeier analysis and differences
were tested with the log-rank test. Uni- and multivariate
binary logistic regression with forced entry was used to
estimate the odds ratios for predictors of peri-operative
Figure 1. Distribution of centers performing ruptured abdominal
aortic aneurysm (rAAA) repair in Sweden, based on size and pro-
portion of endovascular (EVAR) repair.
24 K. Gunnarsson et al.mortality. A two-tailed p-value of < .05 was considered
signiﬁcant. Statistical analyses were performed with IBM
SPSS Statistics software version 22.0 (IBM, Armonk, NY,
USA).
Ethical approval for the project was obtained from the
Regional Ethical Board of Uppsala (Dnr 2014/078).RESULTS
Over the study period, 1,324 operations for infrarenal aortic
rupture were registered in the Swedvasc registry. Twenty
(1.5%) rupture repairs performed at centers not performing
elective aortic surgery were excluded from this analysis. The
remaining 1,304 operations were performed at 29 vascular
centers. EVAR was performed at 17 centers (EVAR ¼ 343;
26.3%) and open repair at all centers (Open repair ¼ 961;
73.7%). Patients treated with EVAR were, on average, older
(76.4 vs. 74.0 years; p < .01), but had the same rate of
cardiac, renal, pulmonary, and cerebrovascular comorbid-
ities as those treated with open repair. A higher proportion
of the EVAR patients were referrals (EVAR 22.7%, openTable 1. Rate of endovascular aneurysm repair (EVAR) per year.
2008e2012
(n rAAA ¼ 1304 a)
2008 (n ¼ 198) 2009 (n ¼ 303
pEVARc 74.6 (176) 62.0 (31) 70.4 (38)
pORc 15.6 (167) 14.2 (21) 13.3 (33)
All centres 26.3 (343) 26.3 (52) 23.4 (71)
Note. Data are % (n). pEVARc ¼ primary EVAR strategy centers; pORc
a Number of ruptured abdominal aortic aneurysm (rAAA) operations rrepair, 4.7%; p < .01), and EVAR patients had a higher mean
pre-operative systolic blood pressure (EVAR 91 mmHg vs.
OR 69 mmHg; p < .01). Most EVARs (91.3%) were per-
formed with percutaneous access. When analyzing outcome
based on operative technique, mortality was lower after
EVAR when compared with open repair at 30 days (EVAR
21.6%, n ¼ 74; open repair 29.6%, n ¼ 288 [p < .01]). There
was no signiﬁcant difference at 1 year (EVAR 32.2%,
n ¼ 108; open repair 36.9%; n ¼ 351 [p ¼ .05]) or 2 years
(EVAR 38.0%, n ¼ 122; open repair 39.4%, n ¼ 369
[p ¼ .19]).
Three referral centers performed EVAR in > 50% (range
58.3e87.7%) of all ruptures over the study period and were
deﬁned as pEVARc (Fig. 1; Table 1). These centers treated a
total of 236 patients, of whom 74.6% underwent EVAR. At
the remaining 26 centers deﬁned as pORc, 1,068 patients
were operated on, of whom 15.6% underwent EVAR (range
0e38.5%). Patient characteristics are presented in Table 2.
Patients treated at pEVARc were more often referrals, had a
higher rate of respiratory comorbidity, and higher registered
pre-operative systolic blood pressure. The pEVARc had a
higher rate of patients with pre-operative loss of con-
sciousness among those treated with EVAR (41.9%) than
the pORc (27.1%; p ¼ .01), while there was no difference in
the rate of pre-operative loss of consciousness in patients
treated with open repair (pEVARc 48.1%, pORc 51.8%;
p ¼ .67). There was no difference in mortality after repair
between pEVARc and pORc (p ¼ .07) (Table 3; Fig. 2A).
Mortality was lower for patients treated with EVAR
compared with open repair, both at pEVARc and pORc.
Patients treated with open repair at pEVARc had a higher 1
and 2 year mortality rate than those undergoing open
repair at pORc (Table 3).
Data were scrutinized to assess the effect on outcome of
the higher rate of referrals at the primary EVAR centers. The
referred patients were younger (73.3 years vs. 74.8 years;
p ¼ .05) and had a higher pre-operative systolic blood
pressure (85.2 mmHg vs. 73.2 mmHg; p ¼ .01) than the
non-referred patients. There was no difference in mortality
between referred and non-referred patients. An exclusion
of the referred cases from the analysis of mortality outcome
at the pEVARc and pORc did not affect the mortality up to 2
years (Table 3), but there was a higher mortality rate over
time in the pEVARc group (p ¼ .03) (Fig. 2B). Subgroup
analyses were performed for octogenarians, showing no
difference in mortality (Table 3).
To assess the effect of other potential confounders, peri-
operative outcome was compared for referral centers and
county hospitals. Thirty day mortality was equal in both) 2010 (n ¼ 293) 2011 (n ¼ 253) 2012 (n ¼ 257) p
81.1 (43) 79.3 (23) 82.0 (41) .10
16.3 (39) 12.5 (28) 22.2 (46) .04
28.0 (82) 20.2 (51) 33.9 (87) .01
¼ primary open repair centers.
egistered in the Swedvasc registry.
Table 2. Patient characteristics.
Overall pEVARc pORc p
Number of centers 29 3 26
Total number of patients 1,304 236 1,068
Number of referred patients (% of total) 123 (9.4) 66 (28.0) 57 (5.3) < .01
Mean age, years (SD) 74.6 (7.9) 74.3 (7.9) 74.7 (7.9) .47
Octogenarian, n (%) 396 (30.4) 69 (29.2) 327 (30.6) .70
Aneurysm diameter, mm (SD) 76.6 (17.3) 76.8 (16.4) 76.6 (17.5) .86
Male sex, n (%) 1,055 (81.0) 193 (81.8) 862 (80.7) .78
Cardiac comorbidity, n (%) 441 (39.8) 61 (43.9) 380 (39.2) .31
Respiratory comorbidity, n (%) 253 (23.4) 42 (36.5) 211 (21.9) < .01
Diabetes, n (%) 134 (11.3) 16 (10.5) 118 (11.4) .79
Mean creatinine level, mmol/L (SD) 118.6 (66.8) 121.2 (84.0) 118.1 (62.5) .56
Cerebrovascular comorbidity, n (%) 160 (14.6) 23 (20.2) 137 (13.9) .09
Lowest systolic blood pressure, mmHg (SD) 74.2 (37.7) 84.3 (38.0) 72.3 (37.4) < .01
Pre-operative loss of consciousness, n (%) 589 (47.3) 93 (43.5) 496 (48.1) .23
Mean follow up, days (SD) 585 (564) 571 (572) 589 (564) .69
Note. pEVARc ¼ primary EVAR strategy centers; pORc ¼ primary open repair centers.
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(overall: referral centers 27.7%, county hospitals 27.9%
[p ¼ .95]; open repair: 32.3% vs. 28.1% [p ¼ .16]; EVAR
21.1% vs. 25.0% [p ¼ .55]). A speciﬁc comparison of pEVARc
and pORc including only referral centers did not affect the
results. Mortality was higher for patients with pre-operative
loss of consciousness both after open repair and EVAR
(overall: loss of consciousness peri-operative mortality
34.0%, no loss of consciousness 22.4% [p < .01]; open
repair 34.6% vs. 25.3% [p < 0.01]; EVAR 31.2% vs. 16.0%
[p < .01]). Mortality was equal at pEVARc and pORc for
patients with pre-operative loss of consciousness. Twelve
centers did not perform any EVAR for ruptures. The open
repair mortality in these centers was 24.3% compared with
32.1% after open repair in centers performing any rupturedTable 3. Post-operative mortality after ruptured abdominal aortic
aneurysm repair.
Mortality pEVARc pORc p
Overall (n) 236 1,068
30 days 66 (28.0) 296 (27.4) .87
1 year 93 (39.9) 366 (34.7) .19
2 years 94 (42.1) 394 (38.3) .28
Excluding referrals (n) 170 1,011
30 days 53 (31.2) 279 (27.6) .36
1 year 71 (42.1) 349 (34.9) .09
2 years 75 (45.0) 377 (38.7) .12
Octogenarians (n) 69 327
30 days 29 (42.0) 130 (39.9) .79
1 year 41 (60.4) 161 (49.7) .41
2 years 44 (66.6) 171 (53.9) .68
Open repair (n) 60 901
30 days 23 (38.3) 265 (29.0) .14
1 year 29 (48.3) 322 (36.1) .03
2 years 31 (52.4) 338 (38.6) .02
EVAR (n) 176 167
30 days 43 (24.4) 31 (18.6) .19
1 year 64 (37.1) 44 (27.0) .06
2 years 66 (38.6) 56 (37.4) .40
Note. Data are n (%). pEVARc ¼ primary endovascular aneurysm
repair (EVAR) strategy centers; pORc¼ primary open repair centers.EVAR (p ¼ .02). However, owing to the lower EVAR mor-
tality, the overall mortality for rupture did not differ be-
tween these groups.
Peri-operative complications are presented in Table 4.
There was a higher proportion of patients with massive
peri-operative bleeding at the pORc, while endoleakage and
need for laparotomy for abdominal compartment syndrome
were more common at pEVARc. A univariate analysis of
predictive factors for peri-operative mortality after rAAA
pointed out age, cardiac disease, renal impairment, and pre-
operative loss of consciousness as predictors. In the multi-
variate analysis, age, renal impairment, and pre-operative
loss of consciousness remained signiﬁcant predictors of
mortality (Table 5).
The incidence of rAAA repair per 100,000 inhabitants >
50 years of age was assessed in the primary uptake area of
pEVARc and pORc, respectively, for the period 2009e12.
Referred patients were allocated to their primary uptake
area in order to avoid distortion of the rate of repair at
referral centers. The incidence of rAAA repair was lower in
pEVARc regions (6.07, 95% conﬁdence interval [CI] 5.01e
7.13) when compared with pORc regions (8.15, 95% CI
7.64e8.66). No correction could be performed for the
prevalence of disease.DISCUSSION
In this population based study the treatment of rAAA based
on primary operative strategy in a nationwide vascular
surgical registry with excellent validity was analyzed. A
quarter of all rAAA repairs in Sweden were performed with
an endovascular technique in the study period, with sig-
niﬁcant variation in the rate of EVAR between centers. From
an international perspective, this is on the same level as the
rate of EVAR treatments performed for rAAA in the USA,
and more than twice the rate of EVAR for ruptures in the
UK.19 The distinct difference in operative strategy between
centers, with selected centers preferring EVAR when
possible and others adhering to open repair as the primary
strategy, offered an opportunity to assess the overall
Figure 2. KaplaneMeier analysis of survival after ruptured abdominal aortic aneurysm repair performed May 2008eDecember 2012 in
Sweden at centers with primary EVAR strategy (pEVARc) and primary open repair strategy (pORc). (A) All patients; (B) excluding referrals.
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strategy in this national cohort. The beneﬁts of population
based studies include the non-selective patient cohort,
which reﬂects contemporary real world practice and
outcome. It has been argued, for instance, that the pro-
portion of general anesthesia in the EVAR arm of the
IMPROVE trial was unexpectedly high, which may have
affected the peri-operative mortality negatively.10,12,20,21
The prospective data collection in this national registryTable 4. Peri-operative complications.
pEVARc pORc p
Total number of patients 236 1,068
Patients with > 5 L
peri-operative bleeding
35 (14.9) 315 (29.5) < .01
Myocardial infarction 11 (6.3) 53 (5.9) .86
Cerebrovascular disease 5 (2.8) 18 (2.1) .57
Renal failure 42 (23.5) 203 (22.3) .78
Multiple organ failure 29 (17.1) 167 (18.5) .75
ICU > 5 days 44 (27.2) 263 (32.1) .23
Intestinal ischemia 14 (7.8) 96 (10.7) .28
ACS 18 (10.1) 64 (6.9) .16
ACS with laparotomy 17 (9.5) 47 (5.1) .03
Reoperation for bleeding 17 (9.5) 68 (7.4) .36
Limb amputation 4 (2.2) 16 (1.7) .55
Graft occlusion 1 (0.7) 10 (1.2) 1.00
Endoleakage 13 (7.4) 12 (1.3) < .01
Distal embolization 9 (5.0) 65 (7.1) .42
Early graft infection 4 (2.2) 6 (0.7) .07
Bowel resection 8 (4.5) 54 (5.9) .60
Note. Data are n (%). pEVARc ¼ primary EVAR strategy centers;
pORc ¼ primary open repair centers; ICU ¼ intensive care unit;
ACS ¼ abdominal compartment syndrome.with predeﬁned variables may, however, limit the compa-
rability of this report to previous trials in certain aspects
(e.g., length of stay and discharge status).
The current study conﬁrms that there is no early or
midterm survival difference between primary open and
endovascular operative strategies for rAAA. No difference
could be found when referrals were excluded from the
analysis. The results of the current study harmonize with
the ﬁndings of the previously published randomized tri-
als.9,10,15 The IMPROVE trial, which had a similar set up to
this study in assessing the role of primary treatment strat-
egy on outcome rather than the role of operative tech-
nique, found a mortality rate of 36.4% in the endovascular
strategy group versus 40.1% in the open repair group.10
Overall, the peri-operative mortality rate in the current
Swedish cohort was lower than in the IMPROVE trial, and in
agreement with the Amsterdam trial.9,10 National differ-
ences in outcome of AAA repair have previously been re-
ported and may explain this variation.7
Peri-operative mortality was lower for patients selected
for EVAR when compared with open repair in the overall
cohort. This is in line with previous population and center
based reports.7,13,19,21 However, this result is affected by
case selection at both pEVARc and pORc, as patients are
selected for treatment with open repair or EVAR based on
aortic anatomy and hemodynamic stability. Indeed, the
equal survival outcome based on primary treatment strat-
egy at center level supports that fact that the improved
peri-operative outcome after EVAR seen in retrospective
studies is likely to be due to selection bias.
The current report indicates that pEVARc treat more
patients with respiratory comorbidity and with less peri-
Table 5. Uni- and multivariate analysis of predictive factors for peri-operative mortality after repair of ruptured abdominal aortic
aneurysm.
Univariate analysis Multivariate analysis
OR 95% CI p OR 95% CI p
Univariate analysis
Repair at primary EVAR strategy center 1.01 0.74e1.39 .94 1.00 0.54e1.87 1.00
Referral 0.68 0.43e1.07 .09 0.50 0.20e1.24 .14
Age per year 1.07 1.05e1.09 < .01 1.06 1.03e1.09 < .01
Female sex 1.40 1.04e1.89 .03 1.43 0.91e2.25 .12
Cardiac disease 1.63 1.24e2.13 < .01 1.19 0.82e1.71 .37
Pulmonary disease 1.46 1.07e1.98 .02 1.37 0.91e2.05 .13
Creatinine (10 mmol/L increase) 1.04 1.02e1.06 < .01 1.07 1.04e1.10 < .01
Aneurysm size per cm 1.06 0.98e1.14 .17 1.01 0.91e1.13 .79
Pre-operative loss of consciousness 1.78 1.39e2.29 < .01 1.55 1.08e2.21 .02
Note. OR ¼ odds ratio; CI ¼ conﬁdence interval; EVAR ¼ endovascular aneurysm repair.
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invasive treatment strategy did not translate into lower
peri-operative mortality, neither overall, nor in subgroup
analyses. The pEVARc had a higher peri-operative mortality
at 1 and 2 years after open repair than pORc. It is reason-
able to believe that the patients selected for open repair at
centers with a primary EVAR strategy had a challenging
anatomy for endovascular treatment. A challenging aortic
neck anatomy is, per se, associated with a higher risk of
peri-operative mortality.22 Nonetheless, the minimally
invasive treatment strategy could be of importance to the
patient. Although data on mode of anesthesia were not
available in the registry, > 90% of EVAR patients were
treated by percutaneous access, indicating a primary local
anesthetic approach in these cases. Laparotomy for
abdominal compartment syndrome (ACS) was performed in
9.5% of patients treated at pEVARc, and was more frequent
than at pORc. ACS is a dreaded complication, associated
with a high mortality rate, and is encountered after both
open and endovascular rAAA repair.23,24 The difference in
frequency of re-laparotomy for ACS may have been affected
by local routines, where some centers preferred to leave
the abdomen open in the early post-operative period after
surgical rAAA repair in order to avoid ACS development.
As the primary EVAR centers in the current study were all
referral centers, a higher rate of referrals were treated in
the pEVARc group. The results were assessed to correct for
this important difference in case selection. Although it was
anticipated that the referral patients would be more com-
plex with a potentially poorer outcome, no indication of this
could be found in the analyses. On the contrary, data
indicate that referrals are more stable pre-operatively,
which is a predictor of better outcome for rAAA repair.9
Exclusion of the referrals from the analyses did not
change the patient characteristics nor the mortality rate.
The KaplaneMeier curve indicates a higher midterm mor-
tality at the pEVARc, which may reﬂect the increased pre-
operative morbidity rate among patients treated at these
centers. The pEVARc were all teaching hospitals with a
relatively high volume of patients. The better outcome
associated with high surgical volume could have been ex-
pected to affect the outcome in the pEVARc in the positivedirection. Despite this, there was no difference in outcome
between the two groups. It is possible that a minimally
invasive primary strategy for treatment of rAAA would
result in a higher rate of active intervention in patients with
rupture. In a recent report, Karthikesalingam et al. reported
a higher overall survival rate for rAAA in the USA compared
with England, owing to a higher rate of active treatment in
the USA.19 This difference in active surgical treatment was
partly due to the higher rate of EVAR for ruptures in the US
setting. In the current report, the incidence of rAAA repair
was surprisingly lower in the regions with pEVARc when
compared with pORc. Although this crude measure does
not correct for potential variations in prevalence of disease,
the ﬁnding at least does not indicate a more liberal
approach to rAAA treatment in the pEVARc in Sweden.
CONCLUSION
In this population based study, there was no difference in
mortality outcome after rAAA repair among centers with a
primary EVAR approach when compared with a primary OR
strategy. Although patients treated with EVAR had lower
short-term mortality compared with those undergoing open
repair, this is likely to be an effect of case selection and did
not result in an overall difference in rAAA mortality based
on primary treatment strategy of centers. The study sup-
ports the ﬁndings of the previously performed randomized
controlled trials in a national registry with conﬁrmed high
validity.
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